TroZonX17 uses funding from LifeArc to advance rapid testing for Chagas disease.
Chagas disease is a debilitating and fatal parasitic disease that impacts over 6 million people in Latin America. Despite advances in...
top of page
Latest News
Search
barrierooney
- Nov 11, 2020
- 3 min
Biomarker Development brings promise of greater access to Chagas Disease diagnosis
Chagas Disease affects about 6–8 million people worldwide1 but less than 1% of the cases are diagnosed . A new study appearing in the...
barrierooney
- Nov 11, 2020
- 1 min
Imperial College London covers our latest publication
Imperial College London has written about our latest publication in Scientific Reports. Reporter Hayley Dunning has written up our...
barrierooney
- Oct 2, 2020
- 1 min
Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera
Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera
bottom of page